This means that individuals who possess at least one ANXA5 rs6854854 C allele are protected against developing MM relative to those with the reference genotype (OR = 0.541; 95% CI = 0.371–0.791; p-value = 0.0013). Here, ANXA5 is linked to Miyoshi myopathy.